e-learning
resources
Glasgow 2004
Monday 06.09.2004
Multicomponent management in pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anxiety and depression in COPD patients: prevalence and risk factors
J. N. De Voogd, J. B. Wempe, G. H. Koëter, K. Postema, A. V. Ranchor, R. Sanderman (Groningen, The Netherlands)
Source:
Annual Congress 2004 - Multicomponent management in pulmonary rehabilitation
Session:
Multicomponent management in pulmonary rehabilitation
Session type:
Thematic Poster Session
Number:
1891
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. N. De Voogd, J. B. Wempe, G. H. Koëter, K. Postema, A. V. Ranchor, R. Sanderman (Groningen, The Netherlands). Anxiety and depression in COPD patients: prevalence and risk factors. Eur Respir J 2004; 24: Suppl. 48, 1891
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Prevalence of anxiety and depression in COPD: are females at higher risk?
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005
Anxiety and depression in patients with asthma
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Anxiety and depression in patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 275s
Year: 2005
Anxiety and depression in patients with asthma
Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control
Year: 2011
Anxiety and depression on exacerbation COPD patients
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Insomnia in COVID-19 survivors: prevalence, severity and associated factors
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
Depression and anxiety in patients with COPD
Source: Eur Respir Rev 2014; 23: 345-349
Year: 2014
Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
Management of depression and anxiety in COPD
Source: Eur Respir Mon 2013; 59: 144-163
Year: 2013
High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001
Anxiety and depression in patients with COPD and chronic respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 80s
Year: 2007
Clinical characteristics and related risk factors of depression in patients with early COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Depression: a characteristic comorbidity of COPD?
Source: Eur Respir J 2014; 44: 570-571
Year: 2014
Anxiety and depression in patients with chronic bronchitis
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
The combined association of anxiety or depression symptoms and obesity with incident asthma: The HUNT study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Prevalence and impact of depression on COPD
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Prevalence depression – Anxiety and impact on quality of life, asthma control and asthma severity in adult patients with asthma
Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control
Year: 2011
Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018
The impact of depression and anxiety on never-smokers COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept